On March 24, 2014, Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced that it intends to file an appeal to challenge the Oslo, Norway District Court’s decision in a patent invalidity case concerning Idenix’s co-owned Norwegian patent NO 330 755 that covers certain 2′-methyl-2′-fluoro nucleoside compounds useful in the treatment of the hepatitis C virus (HCV) and other flaviviridae infections. On last trading day Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) ended up -5.97%lower to close at $6.30 while trading in the range of $6.01 – $6.95. Its return on assets (ROA) is -117.80% while return on investment (ROI) is -116.60%.Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) monthly performance is -11.52%.

Sidoti upgraded shares of Pacific Ethanol (NASDAQ:PEIX) from a neutral rating to a buy rating in a research note released on Thursday morning, TheFlyOnTheWall.com reports. Pacific Ethanol Inc. (NASDAQ:PEIX) in last trading activity ended up at $15.84 with day range of $15.29 – $17.36. Company weekly performance is 6.02% while its quarterly performance stands at 301.01%.Pacific Ethanol Inc. (NASDAQ:PEIX) is -12.97% away from its 52 week high.

Microvision Inc. (NASDAQ:MVIS), a leader in novel ultra-miniature projection display technology, has announced that it has entered into an agreement with United Parcel Service Inc. (NYSE:UPS) and will supply the global leader in logistics, shipping, package distributing and freight forwarding customized PicoP® display modules. Microvision, Inc. (NASDAQ:MVIS) belongs to Technology sector with market capitalization of 64.72 million and has 8.20% insider ownership. In last trading activity company’s stock closed at $2.03 while opening price was $2.26.

Himax Technologies Inc. (NASDAQ:HIMX) slumped 12%. Bank of America Merrill Lynch downgraded the semiconductor maker to underperform, saying the highly competitive market will make margin expansion difficult for Himax On Tuesday shares of Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) opened at $12.15 and closed at $11.86. This year Company’s Earnings per Share (EPS) growth is 0.34 and next year’s estimated EPS growth is 40.42%. Analysts mean target price for Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) is $15.70.

Get Free Updates and Stock Alerts!

*We only send one email per week